Kenryu Nishiyama

3.5k total citations
49 papers, 2.8k citations indexed

About

Kenryu Nishiyama is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Kenryu Nishiyama has authored 49 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Surgery and 16 papers in Oncology. Recurrent topics in Kenryu Nishiyama's work include MicroRNA in disease regulation (10 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Kenryu Nishiyama is often cited by papers focused on MicroRNA in disease regulation (10 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Kenryu Nishiyama collaborates with scholars based in Japan and United States. Kenryu Nishiyama's co-authors include Masayuki Nakagawa, Hideki Enokida, Naohiko Seki, Takeshi Chiyomaru, Kazumori Kawakami, Shuichi Tatarano, Kazuya Kawahara, Robert W. Robey, Susan E. Bates and Hirofumi Yoshino and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Biochemical and Biophysical Research Communications.

In The Last Decade

Kenryu Nishiyama

46 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenryu Nishiyama Japan 24 2.0k 1.4k 824 409 255 49 2.8k
Antonius W.M. Boersma Netherlands 21 1.3k 0.7× 820 0.6× 608 0.7× 182 0.4× 171 0.7× 28 2.0k
Gemma Domínguez Spain 30 2.1k 1.1× 1.4k 1.0× 890 1.1× 156 0.4× 302 1.2× 62 2.9k
Yasunobu Kanamori Japan 26 1.0k 0.5× 452 0.3× 1.1k 1.3× 328 0.8× 186 0.7× 72 2.5k
Alain Thibault United States 24 1.2k 0.6× 584 0.4× 694 0.8× 293 0.7× 477 1.9× 49 2.5k
Herman Burger Netherlands 28 1.2k 0.6× 246 0.2× 1.3k 1.5× 218 0.5× 330 1.3× 45 2.6k
Toshiaki Saeki Japan 32 1.2k 0.6× 600 0.4× 1.7k 2.0× 332 0.8× 476 1.9× 170 3.1k
Terence C. W. Poon Hong Kong 17 1.4k 0.7× 1.1k 0.8× 339 0.4× 193 0.5× 175 0.7× 24 2.0k
Andrea Gsur Austria 27 1.2k 0.6× 262 0.2× 648 0.8× 178 0.4× 419 1.6× 76 2.1k
Graham F. Barnard United States 25 1.6k 0.8× 756 0.6× 1.5k 1.8× 244 0.6× 302 1.2× 63 3.0k
Kenichi Harada Japan 24 1.4k 0.7× 388 0.3× 664 0.8× 714 1.7× 927 3.6× 170 2.9k

Countries citing papers authored by Kenryu Nishiyama

Since Specialization
Citations

This map shows the geographic impact of Kenryu Nishiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenryu Nishiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenryu Nishiyama more than expected).

Fields of papers citing papers by Kenryu Nishiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenryu Nishiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenryu Nishiyama. The network helps show where Kenryu Nishiyama may publish in the future.

Co-authorship network of co-authors of Kenryu Nishiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Kenryu Nishiyama. A scholar is included among the top collaborators of Kenryu Nishiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenryu Nishiyama. Kenryu Nishiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshino, Hirofumi, Takeshi Chiyomaru, Hideki Enokida, et al.. (2011). The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. British Journal of Cancer. 104(5). 808–818. 239 indexed citations
2.
Chiyomaru, Takeshi, Hideki Enokida, Kazumori Kawakami, et al.. (2011). MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urologic Oncology Seminars and Original Investigations. 31(1). 115–123. 86 indexed citations
3.
Yamada, Yasutoshi, Hideki Enokida, Satoko Kojima, et al.. (2010). MiR‐96 and miR‐183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Science. 102(3). 522–529. 184 indexed citations
4.
Chiyomaru, Takeshi, Hideki Enokida, Kazumori Kawakami, et al.. (2010). Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urologic Oncology Seminars and Original Investigations. 30(4). 434–443. 103 indexed citations
5.
Chiyomaru, Takeshi, Hideki Enokida, Shuichi Tatarano, et al.. (2010). miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. British Journal of Cancer. 102(5). 883–891. 282 indexed citations
6.
Enokida, Hideki, Yasushi Okuno, Ryo Kunimoto, et al.. (2009). Identification of novel microRNA targets based on microRNA signatures in bladder cancer. International Journal of Cancer. 125(2). 345–352. 349 indexed citations
7.
Arima, Takashi, Hideki Enokida, Kazuki Toki, et al.. (2007). Nuclear translocation of ADAM‐10 contributes to the pathogenesis and progression of human prostate cancer. Cancer Science. 98(11). 1720–1726. 49 indexed citations
8.
Tachiwada, Tokushi, Zhe‐Sheng Chen, Xiaofang Che, et al.. (2007). Isolation and characterization of arsenite-resistant human epidermoid carcinoma KB cells. Oncology Reports. 18(3). 721–7. 7 indexed citations
9.
Nishiyama, Kenryu, et al.. (2006). Inhibition of 5‐lipoxygenase pathway suppresses the growth of bladder cancer cells. International Journal of Urology. 13(8). 1086–1091. 38 indexed citations
10.
Kawamoto, Ken, Hideki Enokida, Takenari Gotanda, et al.. (2005). p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Biochemical and Biophysical Research Communications. 339(3). 790–796. 74 indexed citations
11.
Enokida, Hideki, et al.. (2004). Renal silica calculi in an infant. International Journal of Urology. 11(2). 119–121. 10 indexed citations
12.
Nakagawa, Masayuki, Hideki Enokida, Tokushi Tachiwada, et al.. (2003). Taxol Resistance and its Reversal by Synthetic Isoprenoids in Human Bladder Cancer Cell Line. Aktuelle Urologie. 34(4). 250–252. 3 indexed citations
13.
Enokida, Hideki, Takenari Gotanda, Hiroyuki Kubo, et al.. (2002). Reversal of P‐Glycoprotein‐mediated Paclitaxel Resistance by New Synthetic Isoprenoids in Human Bladder Cancer Cell Line. Japanese Journal of Cancer Research. 93(9). 1037–1046. 30 indexed citations
14.
Robey, Robert W., Kenryu Nishiyama, Tyler Lahusen, et al.. (2001). Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.. PubMed. 7(1). 145–52. 296 indexed citations
15.
Takebayashi, Yuji, Kenryu Nishiyama, T Shirahama, et al.. (2000). Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder. Cancer. 88(5). 1131–1138. 4 indexed citations
16.
Benito, Marina Álvarez, Robert W. Robey, V. Sandor, et al.. (1998). Using the National Cancer Institute Anticancer Drug Screen to Assess the Effect of MRP Expression on Drug Sensitivity Profiles. Molecular Pharmacology. 54(5). 802–814. 46 indexed citations
17.
Takebayashi, Yuji, Kenryu Nishiyama, Suminori Akiba, et al.. (1997). Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma.. Journal of Clinical Oncology. 15(7). 2570–2578. 96 indexed citations
18.
Shirahama, T, Chohei Sakakura, Elizabeth Sweeney, et al.. (1997). Sphingosine induces apoptosis in androgen‐independent human prostatic carcinoma DU‐145 cells by suppression of bcl‐XL gene expression. FEBS Letters. 407(1). 97–100. 50 indexed citations
19.
Kubo, Hiroyuki, Tomoyuki Sumizawa, K. Koga, et al.. (1996). Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas. International Journal of Cancer. 69(6). 488–494. 17 indexed citations
20.
Nishiyama, Kenryu, T Shirahama, Akihiko Yoshimura, et al.. (1993). Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas. Cancer. 71(11). 3611–3619. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonius W.M. Boersma Breakdown of academic impact, for papers by Gemma Domínguez Breakdown of academic impact, for papers by Yasunobu Kanamori Breakdown of academic impact, for papers by Alain Thibault Breakdown of academic impact, for papers by Herman Burger Breakdown of academic impact, for papers by Toshiaki Saeki Breakdown of academic impact, for papers by Terence C. W. Poon Breakdown of academic impact, for papers by Andrea Gsur Breakdown of academic impact, for papers by Graham F. Barnard Breakdown of academic impact, for papers by Kenichi Harada
Rankless by CCL
2026